Page last updated: 2024-08-24

gemcitabine and Cystadenocarcinoma, Papillary

gemcitabine has been researched along with Cystadenocarcinoma, Papillary in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berkowitz, R; Campos, S; Colella, T; Duska, L; Fuller, A; Gore, S; Lee, H; Matulonis, U; Roche, M; Seiden, MV	1
Kennedy, AW; Khuntia, D; Markman, M; Schwartz, BM	1
Driscoll, DL; Lele, S; Marchetti, D; Odunsi, K; Rodabaugh, K; Villella, J	1

Trials

1 trial(s) available for gemcitabine and Cystadenocarcinoma, Papillary

Article	Year
A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies. Gynecologic oncology, 2003, Volume: 91, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Endometrial Neoplasms; Fallopian Tube Neoplasms; Female; Gemcitabine; Genital Neoplasms, Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Mixed Tumor, Mullerian; Ovarian Neoplasms; Peritoneal Neoplasms; Topotecan	2003

Article

Year

A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies.

Gynecologic oncology, 2003, Volume: 91, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Endometrial Neoplasms; Fallopian Tube Neoplasms; Female; Gemcitabine; Genital Neoplasms, Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Mixed Tumor, Mullerian; Ovarian Neoplasms; Peritoneal Neoplasms; Topotecan

2003

Other Studies

2 other study(ies) available for gemcitabine and Cystadenocarcinoma, Papillary

Article	Year
Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy. Gynecologic oncology, 2003, Volume: 91, Issue:2 Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Deoxycytidine; Female; Gemcitabine; Humans; Ovarian Neoplasms; Radiation-Sensitizing Agents; Radiodermatitis	2003
Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma. Gynecologic oncology, 2004, Volume: 95, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Retrospective Studies; Survival Analysis	2004

Article

Year

Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy.

Gynecologic oncology, 2003, Volume: 91, Issue:2

Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Deoxycytidine; Female; Gemcitabine; Humans; Ovarian Neoplasms; Radiation-Sensitizing Agents; Radiodermatitis

2003

Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma.

Gynecologic oncology, 2004, Volume: 95, Issue:3

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Retrospective Studies; Survival Analysis

2004